Merck & Co., Inc.
Merck & Co., Inc. is a publicly-traded company incorporated in the United States with an IRS Employer Identification Number. The company is an accelerated filer under the Securities Exchange Act of 1934. Its common stock has a par value of $0.50. The company's business strategy is not explicitly stated in the text, but it can be inferred that it is involved in executive compensation and has various equity compensation plans. The company's business segments include Merck Sharp & Dohme Corp. (MSD) and Merck & Co., Inc. The former focuses on the development, manufacturing, and marketing of healthcare solutions, while the latter is engaged in the discovery, development, manufacturing, and marketing of pharmaceuticals and vaccines. The companies' websites are www.merck.com and www.msd.com, respectively. The ticker symbols for Merck & Co., Inc.'s common stock and MSD's common stock are not mentioned in the text. The text includes information about the company's executive compensation, including compensation discussion and analysis, summary compensation table, and various other tables and schedules related to executive compensation. It also mentions the company's equity compensation plans and the number of securities to be issued upon exercise of outstanding options, warrants, and rights. The text also includes information about the company's principal accountant fees and services. The text does not provide any details about the company's business strategy, risks, or policies.